A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Amgen has developed a collection of online resources available to help you learn more about areas of interest.
Do you want to link to this External Site and leave Amgen.com?
YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.
Some of the greatest advances in science are taking place now inside Amgen. Watch and hear the stories from the scientists making it happen.
Invented by Berkeley Lights and developed with early input from Amgen, digital cell biology has immediate applications and abundant long-term potential.
Amgen is using human genetics and cutting-edge biology to search for new checkpoint targets that will work in more types of cancer and more patients.
Why can heart attacks strike people who appear to be perfectly healthy? In some cases, the answer is a little-known risk, lipoprotein(a), which is rarely considered until its impact is felt.
Amgen has built an organization distinguished by world-class scientists with a talent for applying novel approaches to treat disease. Our R&D strategy aims to align and engage our talent, prioritize investments, and seize scientific opportunities.
Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.
The Scientific Advisory Board?provides external scientific review of R&D activities and assists management in its responsibility to make significant scientific judgments related to R&D activities and portfolio.
Some of the greatest advances in science are unfolding now inside Amgen. Find out how Amgen is elevating research and development to a whole new level.
Among the most important steps in the long and careful process to develop new therapies are clinical trials, where people volunteer to receive an experimental new drug or procedure and be observed for its effects.
Amgen supports externally sponsored research to advance our mission of serving the needs of patients.
At Amgen, we continually invest in our manufacturing to strengthen our industry-leading capabilities and extend our global reach. Our commitment is to ensure that all our medicines are available for "every patient, every time."
Biosimilars offer the potential to increase patient access to vital medicines. Amgen is well positioned to leverage its more than 35 years of experience in biotechnology to create high-quality biosimilars and reliably supply them to patients worldwide.